Clinical Trial Update: Study of Nitazoxanide in the Treatment of Chronic Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nitazoxanide for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED